Halozyme Therapeutics, Inc. (HALO)

67.37 +0.01 (+0.01%) USD  |  NASDAQ  |  Mar 06, 16:00
67.98 +0.61 (+0.91%) After-Hours: 20:00
More

Halozyme Therapeutics Extraordinary Items, Income Statement (Per Share Quarterly)

Extraordinary Items, Income Statement (Per Share Quarterly) Chart

View Extraordinary Items, Income Statement (Per Share Quarterly) for HALO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Extraordinary Items, Income Statement (Per Share Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Extraordinary Items, Income Statement (Per Share Quarterly) Range, Past 5 Years

View Extraordinary Items, Income Statement (Per Share Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Extraordinary Items, Income Statement (Per Share Quarterly) Benchmarks

View Extraordinary Items, Income Statement (Per Share Quarterly) Benchmarks
Start Trial
Johnson & Johnson Upgrade
Skye Bioscience, Inc. Upgrade
AIM ImmunoTech, Inc. Upgrade
Stryker Corp. Upgrade
Glaukos Corp. Upgrade